CSI Market
Sign In | Register

Relmada Therapeutics Inc (RLMD) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access RLMD Annual Balance Sheets →
This balance sheet overview for Relmada Therapeutics Inc spans from Mar 31 2025 to Jun 30 2026, showing how the company's assets, liabilities, and equity have evolved across reporting periods.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Jun 30 2025) (Mar 31 2025)
Assets
Cash & cash equivalent11.33
Short-term Investments, Total206.40
Cash & Short-term Investments217.00
Accounts receivable0.01
Other Current Assets0.00
Prepaid Expense, Current AS1.30
Total Current Assets219.04
Tax Assets, Noncurrent0.00
Deferred, Prepaid and Other Assets, Noncurrent1.30
Other Assets, Noncurrent0.00
Total Assets219.06
Liabilities
Accounts Payable, Current AC5.01
Accrued Liabilities, Current5.01
Total Current Liabilities7.42
Total Long-term Debt0.00
Other liabilities, Noncurrent2.48
Total Liabilities12.50
Stockholders' Equity
Common Stock Value0.11
Additional Paid In Capital Common Stock936.68
Retained Earnings / Accumulated Deficit-730.23
Other Equity0.00
Common Stockholder's Equity206.56
Total Stockholder's Equity206.56
Liabilities & Stockholder's Equity219.06
4 historic quarters locked

Sign in to unlock the full Relmada Therapeutics Inc balance sheet history.

Sign In Create Free Account

About Relmada Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001213900-26-086151

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.